Skip to main content

RxNews®

Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.

Leqselvi™ (deuruxolitinib) – New drug approval

July 25, 2024 - Sun Pharma announced the FDA approval of Leqselvi (deuruxolitinib), for the treatment of adults with severe alopecia areata. 

Download PDF

Rx navigation